ACOG's Committee on Practice Bulletins–Obstetrics, in collaboration with Laurence E. Shields, MD; Dena Goffman, MD; and Aaron B. Caughey, MD, PhD, published the updated practice bulletin online ...
Prophylactic tranexamic acid (TXA) during cesarean delivery did not lead to a lower risk of maternal death or blood transfusion, a randomized trial found. Among 11,000 women in 31 U.S. hospitals ...
HemoSonics LLC, a medical device company focused on acute bleeding management, today announced that its Quantra® Hemostasis ...
Alaskans giving birth are experiencing obstetric hemorrhage, or excessive bleeding during or after pregnancy and birth, at increasing rates. The rate in Alaska has climbed from 7.4% to 9.4% between ...
Preparedness and quantification of blood loss for every obstetric patient are crucial for the early identification and treatment of obstetric hemorrhage, according to numerous professional groups ...
The Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A RCT (TXA) study is a randomized placebo-controlled trial of 11,000 women to assess whether tranexamic acid ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
New data suggests dedicated OB hospitalists can reduce complications and improve access, but for CMOs, the bigger question is how continuous obstetric coverage changes clinical governance, risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results